about
Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.Fumanjian, a Classic Chinese Herbal Formula, Can Ameliorate the Impairment of Spatial Learning and Memory through Apoptotic Signaling Pathway in the Hippocampus of Rats with Aβ 1-40 -Induced Alzheimer's Disease.Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling.Long-term safety and tolerability of bapineuzumab in patients with Alzheimer's disease in two phase 3 extension studies.Panax notoginsenoside Rb1 ameliorates Alzheimer's disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expressionPGE2-EP3 signaling pathway contributes to protective effects of misoprostol on cerebral injury in APP/PS1 miceWhat does complement do in Alzheimer's disease? Old molecules with new insights.Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway.Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration.Next generation therapeutics for Alzheimer's disease.The Black Book of Psychotropic Dosing and Monitoring.Effects of donepezil on cognitive functions and the expression level of β-amyloid in peripheral blood of patients with Alzheimer's disease.Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
P2860
Q30651551-63DB3D45-AE58-43B6-9263-35DBCC44C366Q33876308-35B310E6-AB4E-431C-A6BF-AC8A624E82FCQ34096401-C1FBB28A-E4E5-49A8-8105-8FAF236809E8Q37031396-CC607B89-97A7-4EC9-AC74-2B3283877D5BQ37207059-DEB92800-C664-461D-93B3-4EF0A07ED428Q37295322-0CDBD4ED-1BB0-4F87-9EBC-CD3924C305B7Q37368120-7AF084A9-C47C-452F-8A40-7C6C5A5EC35EQ37743448-4D18B407-BD06-49EA-A001-D34F85661740Q38161837-C5C1916F-B14D-4F33-AB25-A6ECBA619C0AQ42648058-B02054DE-66F5-4017-A2DE-F786C7D4D85EQ47642128-FA99B9BF-08A8-4244-80BE-0BA5E598C55DQ49963011-930231B3-B959-4E95-A202-4666F6E02ACBQ55262808-7FF2EEF6-A0B2-4E1D-9FCE-FD59835A5281
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Current therapeutic strategy in Alzheimer's disease
@ast
Current therapeutic strategy in Alzheimer's disease
@en
Current therapeutic strategy in Alzheimer's disease
@nl
type
label
Current therapeutic strategy in Alzheimer's disease
@ast
Current therapeutic strategy in Alzheimer's disease
@en
Current therapeutic strategy in Alzheimer's disease
@nl
prefLabel
Current therapeutic strategy in Alzheimer's disease
@ast
Current therapeutic strategy in Alzheimer's disease
@en
Current therapeutic strategy in Alzheimer's disease
@nl
P2093
P3181
P1476
Current therapeutic strategy in Alzheimer's disease
@en
P2093
P304
P3181
P407
P577
2012-11-01T00:00:00Z